Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Bone Marrow Transplantation|January 10, 2002
Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancerR J Morgan, J H Doroshow, L Leong, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2001
Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium TrialP N Lara, D R Gandara, J Longmate, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 17, 2007
Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium TrialR J Morgan, T W Synold, D Gandara, et al.
British Journal of Cancer|June 13, 2001
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcomeG Somlo, J H Doroshow, T Synold, et al.
Cancer Research|July 14, 1998
Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysisR J Morgan, E M Newman, J H Doroshow, et al.
Blood|April 27, 1999
Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapyG Somlo, I Sniecinski, A ter Veer, et al.
Gynecologic Oncology|December 22, 1999
Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-upR J Morgan, P Braly, G Cecchi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 17, 2004
A study of radiotherapy modalities combined with continuous 5-FU infusion for locally advanced gastrointestinal malignanciesS I Shibata, R Pezner, D Chu, et al.
Pageof 3